Skip Navigation


Journal of Biochemistry Advance Access originally published online on October 6, 2008
Journal of Biochemistry 2008 144(6):701-707; doi:10.1093/jb/mvn131
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
144/6/701    most recent
mvn131v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kurata, N.
Right arrow Articles by Kondo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurata, N.
Right arrow Articles by Kondo, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Authors 2008. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved

Specific Protein Delivery to Target Cells by Antibody-displaying Bionanocapsules

Naoya Kurata1, Takuya Shishido2, Masaru Muraoka2, Tsutomu Tanaka3, Chiaki Ogino4, Hideki Fukuda3 and Akihiko Kondo4,*

1Department of Chemical Science and Engineering; 2Department of Molecular Science and Material Engineering, Graduate School of Science and Technology; 3Organization of Advanced Science and Technology; and 4Department of Chemical Science and Engineering, Graduate School of Engineering, Kobe University, 1-1 Rokkodai, Nada, Kobe 657-8501, Japan

*To whom correspondence should be addressed. Tel: +81 78 803 6196, Fax: +81 78 803 6196, E-mail: akondo{at}kobe-u.ac.jp

Received August 21, 2008; Accepted September 9, 2008


  Abstract

Bionanocapsules (BNCs) are nanoparticles with a high biocompatibility composed of the L protein of the hepatitis B virus surface antigen. BNC can deliver bioactive molecules to hepatocytes efficiently and specifically. However, delivery is limited to hepatocytes and incorporation of proteins into BNC is quite troublesome. Here, in order to alter the specificity of BNC and to achieve efficient protein delivery, we developed engineered BNC displaying the ZZ domain of protein A and incorporating enhanced green fluorescent protein (EGFP) inside the particles using an insect cell expression system. The ZZ domain displayed on the surface of BNC binds to anti-epidermal growth factor receptor (EGFR) antibodies, allowing specific delivery of EGFP to HeLa cells. The engineered BNCs are a promising and powerful tool for efficient and cell-specific protein delivery.

Key Words: antibody-mediated targeting, bionanocapsule, insect cell expression system, protein delivery, ZZ domain

Abbreviations: BNC, bionanocapsule; EGFP, enhanced green fluorescent protein; EGFR, epidermal growth factor receptor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J BiochemHome page
T. Shishido, Y. Azumi, T. Nakanishi, M. Umetsu, T. Tanaka, C. Ogino, H. Fukuda, and A. Kondo
Biotinylated Bionanocapsules for Displaying Diverse Ligands Toward Cell-specific Delivery
J. Biochem., December 1, 2009; 146(6): 867 - 874.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.